The Effects of Corneal Collagen Cross-linking

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The corneal collagen cross-linking treatment has been used with increasing success to treat corneal dystrophies such as "keratoconus." Recent advances have allowed different techniques for performing this cross-linking treatment. This study investigates the effects of corneal cross-linking using different surgical techniques.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rush Eye Associates

Criteria

Inclusion Criteria:

• Age 10-70, willing to participate, diagnosis of corneal ectasia disorder

Exclusion Criteria:

• Unwilling or unable to participate in trial